Purpose This work aims to identify/bridge the gap between Artificial Intelligence (AI) and Healthcare sides in Japan towards developing medical AI fitting into a clinical environment in five years. Moreover, we attempt to confirm the clinical relevance for diagnosis of our research-proven pathology-aware Generative Adversarial Network (GAN)-based medical image augmentation: a data wrangling and information conversion technique to address data paucity. Methods We hold a clinically valuable AI-envisioning workshop among 2 Medical Imaging experts, 2 physicians, and 3 Healthcare/Informatics generalists. A qualitative/quantitative questionnaire survey for 3 project-related physicians and 6 project non-related radiologists evaluates the GAN projects in terms of Data Augmentation (DA) and physician training. Results The workshop reveals the intrinsic gap between AI/Healthcare sides and its preliminary solutions on Why (i.e., clinical significance/interpretation) and How (i.e., data acquisition, commercial deployment, and safety/feeling safe). The survey confirms our pathology-aware GANs' clinical relevance as a clinical decision support system and non-expert physician training tool. Radiologists generally have high expectations for AI-based diagnosis as a reliable second opinion and abnormal candidate detection, instead of replacing them. Conclusions Our findings would play a key role in connecting inter-disciplinary research and clinical applications, not limited to the Japanese medical context and pathology-aware GANs. We find that better DA and expert physician training would require atypical image generation via further GAN-based extrapolation.
Introduction
Convolutional Neural Networks (CNNs) have achieved accurate and reliable Computer-Aided Diagnosis (CAD), occasionally outperforming expert physicians [1, 2] . However, such research results cannot be easily transferred to a clinical environment: Artificial Intelligence (AI) and Healthcare sides have a huge gap around technology, funding, and people [3] ; especially in Japan, the biggest challenge lies in medical data sharing because each hospital has different ethical codes and tends to enclose collected data without annotating them for AI research-this is different from the US, where National Cancer Institute provides annotated medical images [4] . Therefore, we launched Research Center for Medical Big Data in November 2017: collaborating with 6 Japanese medical societies and 6 institutes of informatics, we have collected large-scale annotated medical images for CAD research. Using over 60 million available images, we have achieved prominent research results, presented at major Computer Vision [5] and Medical Imaging conferences [6] . Moreover, we published 6 papers [7] [8] [9] [10] [11] [12] on Generative Adversarial Network (GAN) [13] -based medical image augmentation. Since the GANs can generate realistic samples with desired pathological features via many-to-many mappings, they could overcome the medical data paucity via Data Augmentation (DA) and physician training.
Aiming to further identify/bridge the gap between AI and Healthcare sides in Japan towards developing medical AI fitting into a clinical environment in five years, we hold a workshop for 7 Japanese people with various AI and/or Healthcare background. Moreover, to confirm the clinical relevance for diagnosis of the pathology-aware GAN methods, we conduct a questionnaire survey for 9 Japanese physicians who interpret Computed Tomography (CT) and Magnetic Resonance (MR) images in daily practice. Fig. 1 graphically outlines our investigation.
Contributions. Our main contributions are as follows:
-AI and Healthcare Workshop: We firstly hold a clinically valuable AI-envisioning workshop among Medical Imaging experts, physicians, and Healthcare/Informatics generalists to bridge the gap between AI and Healthcare sides. -Questionnaire Survey for Physicians: We firstly present both qualitative/quantitative questionnaire evaluation results for many physicians about research-proven medical AI. -Information Conversion: Clinical relevance discussions imply that our pathology-aware GAN-based interpolation and extrapolation could overcome medical data paucity via DA and physician training.
Pathology-aware GAN-based Medical Image Augmentation
In terms of interpolation, GAN-based medical image augmentation is reliable because acquisition modalites (e.g., Xray, CT, MR) can display the human body's strong anatomical consistency at fixed position while clearly reflecting inter-subject variability [14, 15] . This is different from natural images, where various objects can appear at any position; accordingly, to tackle large inter-subject, inter-pathology, and cross-modality variability, we proposed to use noise-to-image GANs (e.g., random noise samples to diverse pathological images) for (i) medical DA and (ii) physician training [7] . While the noise-to-image GAN training is much more difficult than training image-to-image GANs [16] (e.g., a benign image to a malignant one), it can increase image diversity for further performance boost. Regarding the DA, the GAN-generated images can improve CAD based on supervised learning [17] [18] [19] . For the physician training, the GANs can display novel desired pathological images and help train medical trainees despite infrastructural/legal constraints [20] . However, we have to find effective loss functions and training schemes for such applications; diversity matters more for the DA to sufficiently fill the real image distribution whereas realism matters more for the physician training not to confuse the trainees.
So, how can we perform clinically relevant GAN-based DA/physician training using only limited annotated images? Always in collaboration with physicians, for improving 2D classification, we combined the noise-to-image and image-to-image GANs [8, 9] ; but, further DA applications require pathology localization for detection and advanced physician training needs atypical image generation, respectively. To meet both clinical demands, we proposed novel 2D/3D bounding box-based GANs conditioned on pathology position/size/appearance; the bounding box-based detection requires much less physicians' annotation effort than segmentation.
In terms of extrapolation, the pathology-aware GANs are promising because common and/or desired medical priors can play a key role in the conditioning-theoretically, infinite conditioning instances, external to the training data, exist and enforcing such constraints have an extrapolation effect via model reduction [21] . For improving 2D detection, we proposed a Conditional Progressive Growing of GANs model that incorporates highly-rough bounding box conditions incrementally into a noise-to-image GAN (i.e., Progressive Growing of GANs [22] ) to place realistic/diverse brain metastases at desired positions/sizes on 256 × 256 MR images [10] . Since the human body is 3D, for improving 3D detection, we proposed 3D Multi-Conditional GAN that translates noise boxes into realistic/diverse 32 × 32 × 32 lung nodules [23] placed naturally at desired position/size/attenuation on CT scans [11] ; inputting the noise box with the surrounding tissues has the effect of combining the noise-to-image and image-to-image GANs.
We succeeded to (i) generate images even realistic for physicians and (ii) improve detection using synthetic training images, respectively; they require different loss functions and training schemes. However, to exploit our pathology-aware GANs as a (i) non-expert physician training tool and (ii) clinical decision support system, we need to confirm their clinical relevance for diagnosis-such data wrangling [24] and information conversion techniques to overcome the data paucity, not limited to our pathology-aware GANs, would become a clinical breakthrough.
Methods

AI and Healthcare Workshop
-Subjects: 2 Medical Imaging experts (i.e., a Medical Imaging researcher and a medical AI startup entrepreneur), 2 physicians (i.e., a radiologist and a psychiatrist), and 3 Healthcare/Informatics generalists (i.e., a nurse and researcher in medical information standardization, a general practitioner and researcher in medical communication, and a medical technology manufacturer's owner and researcher in health disparities)
-Experiments: As its program shows (Table 1) , during the workshop, we conduct 2 activities: (Learning) Know the overview of Medical Image Analysis, including state-of-the-art research, well-known challenges/solutions, and the summary of our pathology-aware GAN projects; (Thinking) Find the intrinsic gap and its solutions between AI researchers and Healthcare workers after sharing their common and different thinking/working styles. This workshop was held on March 17th, 2019 at Nakayama Future Factory, Open Studio, The University of Tokyo, Tokyo, Japan.
Questionnaire Survey for Physicians
-Subjects: 3 physicians (i.e., a radiologist, a psychiatrist, and a physiatrist) committed to (at least one of) our pathology-aware GAN projects and 6 project non-related radiologists without much AI background. This paper's authors are surely not included. 
Results
Workshop Results
We show the summary of clinically-relevant findings from this Japanese workshop.
Gap between AI and Healthcare Sides Gap 1: AI, including Deep Learning, does not provide clear decision criteria, does it make physicians reluctant to use it in a clinical environment, especially for diagnosis?
-Healthcare side: We rather expect applications other than diagnosis. If we use AI for diagnosis, instead of replacing physicians, we suppose a reliable second opinion, such as alert to avoid misdiagnosis, based on various clinical data not limited to images-every single diagnostician is anxious about their diagnosis. AI only provides minimum explanation, such as a heatmap showing attention, which makes persuading not only the physicians but also patients difficult; thus, the physicians' intervention is essential for intuitive explanation. Methodological safety and feeling safe are different. In this sense, pursuing explainable AI generally decreases AI's diagnostic accuracy [26] , so physicians should still serve as mediators by engaging in high-level conversation or interaction with patients. Moreover, according to the medical law in most countries including Japan, only doctors can make the final decision. The first autonomous AI-based diagnosis without a physician was cleared by the Food and Drug Administration in in 2018 [27] , but such a case is exceptional.
-AI side: Compared with other systems or physicians, Deep Learning's explanation is not particularly poor, so we require too severe standards for AI; the word AI is excessively promoting anxiety and perfection. If we could thoroughly verify the reliability of its diagnosis against physicians by exploring uncertainty measures [28] , such intuitive explanation would be optional.
Gap 2:
Are there any benefits to actually introducing medical AI?
-Healthcare side: After all, even if AI can achieve high accuracy and convenient operation, hospitals would not introduce it without any commercial benefits. Moreover, small clinics, where physicians are desperately needed, often do not have CT or MR scanners [29] .
-AI side: The commercial deployment of medical AI is strongly tied to diagnostic accuracy; so, if it can achieve significantly outstanding accuracy at various tasks in the near future, patients would not visit hospitals/clinics without AI. Accordingly, introducing medical AI would become profitable in five years.
Gap 3: Is medical AI's diagnostic accuracy reliable?
-Healthcare side: To evaluate AI's diagnostic performance, we should consider many metrics, such as sensitivity and specificity. Moreover, its generalization ability for medical data highly relies on inter-scanner/inter-individual variability [30] . How can we evaluate whether it is suitable as a clinically applicable system? -AI side: Generally, alleviating the risk of overlooking the diagnosis is the most important, so sensitivity matters more than specificity unless their balance is highly disturbed. Recently, such research on medical AI that is robust to different datasets is active [31] .
How to Develop Medical AI Fitting into a Clinical Environment in Five Years
Why: Clinical significance/interpretation -Challenges: We need to clarify which clinical situations actually require AI introduction. Moreover, AI's early diagnosis might not be always beneficial for patients.
-Solutions: Due to nearly endless disease types and frequent misdiagnosis coming from physicians' fatigue, we should use it as alert to avoid misdiagnosis [32] (e.g., reliable second opinion), instead of replacing physicians. It should help prevent oversight in diagnostic tests not only with CT and MR, but also with blood data, chest X-ray, and mammography before taking CT and MR [33] . It could be also applied to segmentation for radiation therapy [34] , neurosurgery navigation [35] , and pressure ulcers' echo evaluation. Along with improving the diagnosis, it would also make the physicians' workflow easier, such as by denoising [36] . Patients should decide whether they accept AI-based diagnosis under informed consent. How: Data acquisition -Challenges: Ethical screening in Japan is exceptionally strict, so acquiring and sharing large-scale medical data/annotation are challenging-it also applies to Europe due to General Data Protection Regulation [37] . Considering the speed of technological advances in AI, adopting it for medical devices is difficult in Japan, unlike in medical AI-ready countries, such as the US, where the ethical screening is relatively loose in return for the responsibility of monitoring system stability. Moreover, whenever diagnostic criteria changes, we need further reviews and software modifications; for example, the Tumor-lymph Node-Metastasis (TNM) classification [38] criteria changed for oropharyngeal cancer in 2018 and for lung cancer in 2017, respectively. Diagnostic equipment/target changes also require large-scale data/annotation acquisition again.
-Solutions: For Japan to keep pace, the ethical screening should be adequate to the other leading countries. Currently, overseas research and clinical trials are proceeding much faster, so it seems better to collaborate with overseas companies than to do it in Japan alone. Moreover, complete medical checkup, which is extremely costly, is unique in East Asia, thus Japan could be superior in individuals' multiple medical data-Japan is the only country, where most workers aged 40 or over are required to have medical checkups once a year regardless of their health conditions by the Industrial Safety and Health Act [39] . To handle changes in diagnostic criteria/equipment and overcome dataset/task dependency, it is necessary to establish a common database creation workflow [40] by regularly entering electronic medical records into the database. For reducing data acquisition/annotation cost, AI techniques, such as GAN-based DA [11] and domain adaptation [41] , would be effective.
How: Commercial deployment -Challenges: Hospitals currently do not have commercial benefits to actually introduce medical AI.
-Solutions: For example, it would be possible to build AI-powered hospitals [42] operated with less staff. Medical manufacturers could also standardize data format [43] , such as for X-ray, and provide some AI services. Many IT giants like Google are now working on medical AI to collect massive biomedical datasets [44] , so they could help rural areas and developing countries, where physician shortage is severe [29] , at relatively low cost.
How: Safety and feeling safe -Challenges: Considering multiple metrics, such as sensitivity and specificity [45] , and dataset/task dependency [46] , accuracy could be unreliable, so ensuring safety is challenging. Moreover, reassuring physicians and patients is important to actually use AI in a clinical environment [47] .
-Solutions: We should integrate various clinical data, such as blood test biomarkers and multiomics, with images [33] . Moreover, developing bias-robust technology is important since confounding factors are inevitable [48] . To prevent oversight, prioritizing sensitivity over specificity is essential while maintaining a balance [49] . We should also devise education for medical AI users, such as result interpretation, to reassure patients [50] .
Questionnaire Survey Results
We show the questions and Japanese physicians' corresponding answers. -Free comments (one comment for each physician) -As radiologists, we need AI-based diagnosis during image interpretation as soon as possible.
-It is common to conduct further medical examinations when identifying disease is difficult from CT/MR images; thus, if AI-based diagnosis outperforms that of physicians, such clinical decision support systems could prevent unnecessary examinations. Moreover, recently lung cancer misdiagnosis occurred in Japan, but AI technologies may prevent such death caused by misdiagnosis.
Bridging the gap between AI and Healthcare sides: towards developing clinically relevant AI-powered diagnosis systems 7 -The lack of diagnosticians is very evident in Healthcare, so AI has great potential to support us. It may be already applicable without severe problems for typical disease cases. -I am looking forward to its practical applications, especially at low or zero price.
-I would like to use AI-based diagnosis as a kind of data, but it is yet uncertain how much I trust AI.
-I am wondering whether such systems will become popular due to practical problems such as introduction cost.
-The definition of accurate and reliable is unclear. Since a physician's annotation is always subjective, we cannot claim that AI-based diagnosis is really correct even if AI diagnoses similarly to the specific physician. Because I do not believe other physicians' diagnosis, but my own eyes, I would use AI just to identify abnormal candidates.
As expected, the project-related physicians are AI-enthusiastic while the project non-related radiologists are also generally very positive about the medical AI. Many of them appeal the necessity of AI-based diagnosis for more reliable diagnosis because of the lack of physicians. Meanwhile, other physicians worry about its cost and reliability. We may be able to persuade them by showing expected profitability (e.g., currently CT scanners have an earning rate 16% and CT scans require 2-20 minutes for interpretation in Japan); similarly, we can explain how experts annotate medical images and AI diagnoses disease based on them (e.g., multiple physicians, not a single one, can annotate the images via discussion). -Free comments (one comment for each physician) -Achieved accuracy improvement shows its superiority in identifying diverse disease.
-It would be effective, especially as rare disease training data.
-I am looking forward to the future with advanced GAN technology.
-It significantly improves detection sensitivity; but I am also curious about its influence on other metrics, such as specificity.
-If Deep Learning could be more effective, we should introduce it; but anonymization would be important for privacy preservation. -Achieved accuracy improvement shows its superiority in identifying diverse disease.
-It would be effective to train AI on data-limited disease, but which means that AI is inferior to humans.
-It would be helpful if such DA improves accuracy and reliability. Since I am not familiar with AI and a generator/classifier's failure judgment mechanisms, I am uncertain whether it will really increase reliability though.
As expected, the project-related physicians are very positive about the GAN-based DA while the project nonrelated radiologists are also positive. Many of them are satisfied with its achieved accuracy/sensitivity improvement when available annotated images are limited. However, similarly to their opinions on general Medical Image Analysis, some physicians question its reliability. -Which specific usage is assumed for such physician training? -I cannot state an opinion before actually using the system, but I strongly recognize the importance of looking at real images. -I do not exactly understand in which situation such physician training is used, but eventually training with realistic images would be also helpful. However, if real images are available, using them would be better.
We generally receive neutral feedback because we do not provide a concrete physician training tool, but instead general pathology-aware generation ideas with example synthesized images-thus, some physicians are positive, and some are not. A physician provides a key idea about a pathology-coverage rate for medical student/expert physician training, respectively; for extensive physician training with GAN-generated atypical images, along with pathology-aware GAN-based extrapolation, further GAN-based extrapolation would be valuable.
Question 4:
Any comments or suggestions about our pathology-aware GAN projects towards developing clinically relevant AI-powered systems based on your daily diagnosis experience?
-This approach will change the way physicians work. I have high expectations for AI-based diagnosis, so I hope it to overcome the legal barrier. -For now, please show small abnormal findings, such as nodules and ground glass opacities-it would halve radiologists' efforts. Then, we could develop accurate diagnosis step by step. -Showing abnormal findings with their shapes/sizes/disease names would increase diagnosis accuracy. But I also would like to know how diagnosticians' roles change after all. -I hope that this approach will lead to physicians' work reduction in the future.
-Please develop reliable AI systems by increasing accuracy with the GAN-based image augmentation.
-GANs can generate typical images, but not atypical images; this would be the next challenge.
-AI can alert physicians to detect typical cases, and thus decrease interpretation time; however, it may lead to the diagnosticians' easy diagnosis without much consideration. Especially in Japan, we currently often conduct unnecessary diagnostic tests, so the diagnosticians should be more responsible of their own duties after introducing AI.
Most physicians look excited about our pathology-aware GAN-based image augmentation projects and express their clinically relevant requests. The next steps lie in performing further GAN-based extrapolation, developing clinician-friendly systems with new practice guidelines, and overcoming legal/financial constraints.
Conclusion
Our first clinically valuable AI-envisioning workshop between people with various AI and/or Healthcare background reveals the intrinsic gap between both sides and its preliminary solutions. We believe that the solutions on Why (i.e., clinical significance/interpretation) and How (i.e., data acquisition, commercial deployment, and safety/feeling safe) would play a key role in connecting inter-disciplinary research and clinical applications.
After conducting a questionnaire survey for physicians, we confirm our pathology-aware GANs' clinical relevance for diagnosis as a clinical decision support system and non-expert physician training tool. We find that better DA and expert physician training require further atypical image generation; therefore, for better GAN-based extrapolation, we plan to conduct (i) generation by parts with coordinate conditions [51] , (ii) generation with both image and radiogenomic conditions, and (iii) transfer learning among different body parts and disease types. Whereas this paper only explores the Japanese medical context and pathology-aware GANs, our findings are more generally applicable.
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